Lv7
4880 积分 2023-03-27 加入
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
9天前
已完结
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer
9天前
已完结
中国药物性肝损伤诊治指南(2023年版)
13天前
已完结
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
16天前
已完结
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
16天前
已完结
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial
1个月前
已完结
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
2个月前
已完结
鄂公网安备 42011102003731号
